October 9, 2014 / 10:55 AM / 3 years ago

Endo to buy Auxilium for $2.6 bln, Auxilium drops QLT deal

Oct 9 (Reuters) - Endo International Plc said it would buy Auxilium Pharmaceuticals Inc in a deal valued at $2.6 billion, including the repayment and assumption of debt.

Endo’s offer of $33.25 per share represents a premium of about 12 percent to Auxilium’s Wednesday close and is higher than Endo’s previous offer of $28.10.

The deal has an equity value of $1.67 billion, according to a Reuters calculation.

As part of the deal, Auxilium terminated its proposed merger agreement with Canadian eye-drug maker QLT Inc. (Reporting by Ankur Banerjee in Bangalore; Editing by Savio D‘Souza)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below